These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

620 related articles for article (PubMed ID: 11695550)

  • 1. The syrian hamster embryo (SHE) cell transformation assay: review of the methods and results.
    Mauthe RJ; Gibson DP; Bunch RT; Custer L
    Toxicol Pathol; 2001; 29 Suppl():138-46. PubMed ID: 11695550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of a two-stage Syrian hamster embryo cell transformation assay to cigarette smoke particulate matter.
    Breheny D; Zhang H; Massey ED
    Mutat Res; 2005 May; 572(1-2):45-57. PubMed ID: 15790489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the predictiveness of the Syrian hamster embryo cell transformation assay for determining the rodent carcinogenic potential of single ring aromatic/nitroaromatic amine compounds.
    Kerckaert GA; LeBoeuf RA; Isfort RJ
    Toxicol Sci; 1998 Feb; 41(2):189-97. PubMed ID: 9520355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of the Syrian hamster embryo cell transformation assay for carcinogenicity prediction of chemicals currently being tested by the National Toxicology Program in rodent bioassays.
    Kerckaert GA; Brauninger R; LeBoeuf RA; Isfort RJ
    Environ Health Perspect; 1996 Oct; 104 Suppl 5(Suppl 5):1075-84. PubMed ID: 8933057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Committee on Mutagenicity of Chemicals in Food, Consumer Products and the Environment ILSI/HESI research programme on alternative cancer models: results of Syrian hamster embryo cell transformation assay. International Life Sciences Institute/Health and Environmental Science Institute.
    Farmer PB
    Toxicol Pathol; 2002; 30(4):536-8. PubMed ID: 12187945
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of the standard and reduced pH Syrian hamster embryo (SHE) cell in vitro transformation assays in predicting the carcinogenic potential of chemicals.
    Isfort RJ; Kerckaert GA; LeBoeuf RA
    Mutat Res; 1996 Sep; 356(1):11-63. PubMed ID: 8841474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pH 6.7 Syrian hamster embryo cell transformation assay for assessing the carcinogenic potential of chemicals.
    LeBoeuf RA; Kerckaert GA; Aardema MJ; Gibson DP; Brauninger R; Isfort RJ
    Mutat Res; 1996 Sep; 356(1):85-127. PubMed ID: 8841476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of the Syrian hamster embryo cell transformation assay for determining the carcinogenic potential of heavy metal compounds.
    Kerckaert GA; LeBoeuf RA; Isfort RJ
    Fundam Appl Toxicol; 1996 Nov; 34(1):67-72. PubMed ID: 8937893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testing of known carcinogens and noncarcinogens in the Syrian hamster embryo (SHE) micronucleus test in vitro; correlations with in vivo micronucleus formation and cell transformation.
    Fritzenschaf H; Kohlpoth M; Rusche B; Schiffmann D
    Mutat Res; 1993 Sep; 319(1):47-53. PubMed ID: 7690458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell transformation assays.
    Costa M; Sutherland JE
    Curr Protoc Toxicol; 2001 May; Chapter 3():Unit3.4. PubMed ID: 23045050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A refined protocol for conducting the low pH 6.7 Syrian hamster embryo (SHE) cell transformation assay.
    Custer L; Gibson DP; Aardema MJ; LeBoeuf RA
    Mutat Res; 2000 Nov; 455(1-2):129-39. PubMed ID: 11113472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neonatal mouse model: review of methods and results.
    McClain RM; Keller D; Casciano D; Fu P; MacDonald J; Popp J; Sagartz J
    Toxicol Pathol; 2001; 29 Suppl():128-37. PubMed ID: 11695548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recommended protocol for the Syrian hamster embryo (SHE) cell transformation assay.
    Maire MA; Pant K; Phrakonkham P; Poth A; Schwind KR; Rast C; Bruce SW; Sly JE; Bohnenberger S; Kunkelmann T; Schulz M; Vasseur P
    Mutat Res; 2012 Apr; 744(1):76-81. PubMed ID: 22198328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternative models for carcinogenicity testing.
    Cohen SM; Robinson D; MacDonald J
    Toxicol Sci; 2001 Nov; 64(1):14-9. PubMed ID: 11606797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The testing of chemicals in the Syrian hamster embryo (SHE) cell transformation assay for assessment of carcinogenic potential.
    Engelhardt G; Schwind KR; Mussler B
    Toxicol In Vitro; 2004 Apr; 18(2):213-8. PubMed ID: 14757112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphological transformation of Syrian hamster embryo cells at pH 6.7 by bemitradine, a nongenotoxic carcinogen.
    Oshiro Y; Balwierz PS; Morris DL; Alden CL; Bunch RT
    In Vitr Mol Toxicol; 2001; 14(2):121-7. PubMed ID: 11690565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The results of five coded compounds: genistein, metaproterenol, rotenone, p-anisidine and resorcinol tested in the pH 6.7 Syrian hamster embryo cell morphological transformation assay.
    Harvey JS; Howe JR; Lynch AM; Rees RW
    Mutagenesis; 2005 Jan; 20(1):51-6. PubMed ID: 15671057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of Syrian hamster embryo and BALB/c 3T3 cell transformation for assessing the carcinogenic potential of chemicals.
    LeBoeuf RA; Kerckaert KA; Aardema MJ; Isfort RJ
    IARC Sci Publ; 1999; (146):409-25. PubMed ID: 10353397
    [No Abstract]   [Full Text] [Related]  

  • 19. CB6F1-rasH2 mouse: overview of available data.
    Usui T; Mutai M; Hisada S; Takoaka M; Soper KA; McCullough B; Alden C
    Toxicol Pathol; 2001; 29 Suppl():90-108. PubMed ID: 11695565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalidation study of the Syrian hamster embryo (SHE) cell transformation assay at pH 7.0 for assessment of carcinogenic potential of chemicals.
    Maire MA; Pant K; Poth A; Schwind KR; Rast C; Bruce SW; Sly JE; Kunz-Bohnenberger S; Kunkelmann T; Engelhardt G; Schulz M; Vasseur P
    Mutat Res; 2012 Apr; 744(1):64-75. PubMed ID: 22227405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.